Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending October 02, 2007. The report details a specific corporate action regarding the repurchase of the company's own shares, authorized by shareholders at the Annual General Meeting on May 23, 2007.
Key Financial Metrics
The filing does not provide data on revenue, profit, cash flow, margins, debt, or liquidity. The only financial metric disclosed is the share repurchase transaction:
- Shares Purchased: 2,050,000 Ordinary shares of 25 pence each.
- Purchase Price: 1,318.36 pence per share.
- Transaction Date: October 02, 2007.
Material Changes
Following the repurchase, the company's Treasury share holdings increased to 419,289,158 shares. This represents 7.484% of the total voting rights in the Company. The number of shares in issue (excluding Treasury shares) stands at 5,604,897,020.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It explicitly states that the announcement does not constitute an offer or solicitation to purchase securities and is made in conformity with the Financial Services Authority's Disclosure and Transparency Rules.
Investor Verification Points
- Verify the total number of shares in issue (5,604,897,020) for calculating disclosure thresholds under FSA rules.
- Confirm the updated Treasury share percentage (7.484%) for voting rights calculations.
- Note that this filing is a regulatory disclosure of a share buyback and does not contain operational or financial performance results.